Within3 Introduces Dataverse to Expand Real-World Data Coverage for Pharma Launch Intelligence
Within3 today announced Dataverse, an ecosystem that connects the company’s Launch Intelligence platform with a select, innovative group of partners that bring additional real-world data sources, creating a single governed environment that serves as the foundation to a robust intelligence engine – helping generate stronger evidence for faster, better decisions throughout the pharma launch lifecycle.
Within3 Names Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting
Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting. McKinnon joins from Oracle, where he most recently served as Global Head of Commercial Consulting, Life Sciences.
Within3 Unveils Launch Intelligence™ and Know Everything™ to Transform How Life Sciences Teams Make Critical Decisions
Within3, the company that pioneered insights management for life sciences, today unveiled Launch Intelligence™, powered by Know Everything™, marking the next chapter in how life sciences teams make critical decisions. By unifying fragmented data into a single, real-time market view, Launch Intelligence™ ensures teams can act with clarity in an environment where product launches carry enormous cost and risk.
Within3 Unveils Major Insights Management Platform Enhancements Capable of Eliminating 90% of the Workload Associated with Insights Moderation, Analysis, and Reporting
Within3 today announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The company’s updated Insights Management Platform, built on proven AI capabilities and unique to the market, allows life science companies to rethink how they engage audiences, drive insights, and iterate on business strategies.
Within3 and Reuters Health Announce State of Medical Affairs Insights Management Survey Results
Within3 today announced the results of a comprehensive survey of medical affairs professionals across pharmaceutical and biotechnology organizations.
Within3 Announces the Evolution of Industry-First Insights Management Platform
Within3 announces new enhancements to its industry-first insights management platform for pharmaceutical and medical device companies. With more than 40 engagement applications across the platform, life science organizations can now better understand their markets, increase the volume and diversity of insights, and accelerate decision-making across the drug development lifecycle – in a single, intuitive, and bespoke platform.
Within3 Reimagines Life Science Communications to Address Insights Gap with Industry-First, Holistic Platform
Within3’s hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That’s why multidisciplinary teams in the largest pharmaceutical and medical device companies use Within3 to run engagement programs like advisory boards, congress huddles, and publication planning.
